Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Toyota Motor Corp (TM) vs 10X Genomics Inc (TXG) Price & Performance

Toyota Motor CorpTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Toyota Motor Corp vs 10X Genomics Inc — how do they compare? Toyota Motor Corp trades at $184.98 (market cap $217.38B), while 10X Genomics Inc trades at $81 (market cap $10.07B). The key difference: Toyota Motor Corp is far larger — about 21.6× 10X Genomics Inc's market cap, and Toyota Motor Corp pays a 3.37% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Toyota Motor Corp for 116 Days and 10X Genomics Inc for 91 Days on average.

TMTXG
Market Cap
$217.38B$10.07B
Volume
291,2505,657,286
Sector
Consumer CyclicalHealth
52-Week High
$248.29$97.74
52-Week Low
$166.50$11.48
Typical Hold Time
116 Days91 Days
Enterprise Value
$410.96B$9.59B
Dividend Yield
3.37%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Toyota Motor Corp

Toyota Motor trades at $184.84, up 1.06% with bearish technical signals despite strong fundamentals. The stock shows attractive valuation metrics with P/E of 8.38 and P/B of 0.93, while delivering consistent earnings beats. Recent U.S. sales growth and electrification progress contrast with China market challenges and production disruptions from Thailand floods.

Toyota presents a value opportunity with solid profitability and market share gains, though technical weakness and regional sales pressures warrant caution. The company's electrification investments and strong U.S. position support long-term growth, while currency risks and competitive pressures remain key monitoring points for investors.

10X Genomics Inc

10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.

The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TM
87% Buy13% Sell
Avg holding period · 116 Days
TXG
97% Buy3% Sell
Avg holding period · 91 Days

Top news

Latest headlines on both assets

About Toyota Motor Corp

Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.

Read more on TM →

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG →